☆ 4.3 Article

Infliximab therapy decreases the levels of TNF- and IFN- mRNA in colonic mucosa of ulcerative colitis

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)

Journal

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Volume 44, Issue 6, Pages 727-735

Publisher

TAYLOR & FRANCIS LTD

DOI: 10.1080/00365520902803507

Keywords

Cytokines; immunohistochemistry; inflammatory bowel disease; quantitative real-time PCR

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

Objective. The mechanisms of action of infliximab (IFX) in the treatment of ulcerative colitis (UC) are poorly understood. The aim of the study was to investigate the changes in tissue expression of tumor necrosis factor-alpha (TNF-) and other cytokines in UC patients receiving IFX treatment. Material and methods. The levels of TNF-, interleukin (IL)-10, IL-4, and interferon-gamma (IFN-) mRNA in colonic biopsies from 32 UC patients during IFX treatment were measured by real-time polymerase chain reaction (PCR) and compared with those of 19 controls. Immunohistochemistry was performed to characterize the changes of inflammatory cells during treatment. Results. IFX reduced the expression of TNF- and IFN- mRNA, but not that of IL-10 and IL-4 mRNA. Reductions in TNF- mRNA were correlated to clinical and endoscopic improvements, and normalization of TNF- mRNA was obtained in patients with healed mucosa. The numbers of T lymphocytes and macrophages were significantly decreased in patients with healed mucosa after IFX treatment, although compared to normal controls, there were still increased levels of TNF--positive cells after treatment. Conclusions. IFX induced down-regulation of the mucosal TNF- and IFN- mRNA expression in UC patients. The numbers of T lymphocytes and macrophages were significantly decreased in patients with endoscopically healed mucosa after IFX treatment.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Quantitative real-time PCR analysis of bacterial biomarkers enable fast and accurate monitoring in inflammatory bowel disease

Efe Sezgin, Gamze Terlemez, Berkay Bozkurt, Goksel Bengi, Hale Akpinar, Ilker Buyuktorun

Summary: This study aims to investigate whether qPCR analysis of common candidate bacteria from a patient's fecal microbiome can serve as a fast and reliable personalized microbial biomarker for monitoring the disease course of inflammatory bowel diseases (IBD). The results showed that the relative abundance of anti-inflammatory and beneficial bacteria, such as Faecalibacterium prausnitzii, Akkermansia muciniphila, and Streptococcus thermophilus, was significantly lower in IBD patients compared to the control group. The relative abundance of these common species was also correlated with the severity of IBD. The qPCR analysis demonstrated lower variance and higher statistical power compared to NGS data, suggesting that it can be a powerful and cost-effective approach for monitoring disease status and identifying personalized treatment options for IBD patients.

PEERJ (2022)